The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-08-26
DOI
10.1038/srep13001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclic AMP/PKA-Promoted Apoptosis: Insights from Studies of S49 Lymphoma Cells
- (2014) P. Insel et al. HORMONE AND METABOLIC RESEARCH
- Review of Natural Compounds for Potential Skin Cancer Treatment
- (2014) Tawona Chinembiri et al. MOLECULES
- Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management
- (2013) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathway
- (2013) Virginie Follin-Arbelet et al. CANCER LETTERS
- Forskolin Compared with Beclomethasone for Prevention of Asthma Attacks: A Single-Blind Clinical Trial
- (2013) M Huerta et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Emerging biological insights and novel treatment strategies in multiple myeloma
- (2012) Massimo Gentile et al. EXPERT OPINION ON EMERGING DRUGS
- Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination Screening
- (2012) R. J. Rickles et al. MOLECULAR CANCER THERAPEUTICS
- Latest advances and current challenges in the treatment of multiple myeloma
- (2012) Anuj Mahindra et al. Nature Reviews Clinical Oncology
- Cancer prevention and treatment using combination therapy with plant- and animal-derived compounds
- (2012) Jacinta Uzoigwe et al. Expert Review of Clinical Pharmacology
- Practical management of adverse events in multiple myeloma: Can therapy be attenuated in older patients?
- (2011) Antonio Palumbo et al. BLOOD REVIEWS
- Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model
- (2011) Virginie Follin-Arbelet et al. BMC CANCER
- Tocotrienols fight cancer by targeting multiple cell signaling pathways
- (2011) Ramaswamy Kannappan et al. Genes and Nutrition
- Increased Expression of the Pro-apoptotic Protein BIM, a Mechanism for cAMP/Protein Kinase A (PKA)-induced Apoptosis of Immature T Cells
- (2011) Alexander C. Zambon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
- (2011) Mu Hao et al. LEUKEMIA & LYMPHOMA
- Multiple Myeloma
- (2010) Jacob Laubach et al. Annual Review of Medicine
- Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies
- (2010) R. J. Rickles et al. BLOOD
- Management of treatment-related adverse events in patients with multiple myeloma
- (2010) María-Victoria Mateos CANCER TREATMENT REVIEWS
- Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim
- (2010) Diane Moujalled et al. EMBO REPORTS
- Management of disease- and treatment-related complications in patients with multiple myeloma
- (2010) Francesca Gay et al. MEDICAL ONCOLOGY
- Multitargeted therapy of cancer by green tea polyphenols
- (2008) Naghma Khan et al. CANCER LETTERS
- Multi-targeted therapy of cancer by genistein
- (2008) Sanjeev Banerjee et al. CANCER LETTERS
- Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
- (2008) Ajaikumar B. Kunnumakkara et al. CANCER LETTERS
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
- (2008) G Kroemer et al. CELL DEATH AND DIFFERENTIATION
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started